Selected article for: "action perspective and acute respiratory syndrome coronavirus"
Author: Dejani, Naiara Naiana; Elshabrawy, Hatem A.; Bezerra Filho, Carlos da Silva Maia; de Sousa, Damião Pergentino
Title: Anticoronavirus and Immunomodulatory Phenolic Compounds: Opportunities and Pharmacotherapeutic Perspectives
  • Cord-id: upkq32m4
  • Document date: 2021_8_23
    • ID: upkq32m4
    Snippet: In 2019, COVID-19 emerged as a severe respiratory disease that is caused by the novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The disease has been associated with high mortality rate, especially in patients with comorbidities such as diabetes, cardiovascular and kidney diseases. This could be attributed to dysregulated immune responses and severe systemic inflammation in COVID-19 patients. The use of effective antiviral drugs against SARS-CoV-2 and modulation o
    Document: In 2019, COVID-19 emerged as a severe respiratory disease that is caused by the novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The disease has been associated with high mortality rate, especially in patients with comorbidities such as diabetes, cardiovascular and kidney diseases. This could be attributed to dysregulated immune responses and severe systemic inflammation in COVID-19 patients. The use of effective antiviral drugs against SARS-CoV-2 and modulation of the immune responses could be a potential therapeutic strategy for COVID-19. Studies have shown that natural phenolic compounds have several pharmacological properties, including anticoronavirus and immunomodulatory activities. Therefore, this review discusses the dual action of these natural products from the perspective of applicability at COVID-19.

    Search related documents:
    Co phrase search for related documents
    • absence presence and acid inducible: 1
    • absence presence and acid inducible gene: 1
    • absence presence and acid result: 1, 2
    • absence presence and activation result: 1, 2
    • absence presence and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • absence presence and acute lung injury: 1, 2, 3
    • absence presence and acute myocarditis: 1
    • absence presence and acute phase: 1, 2, 3, 4, 5, 6, 7, 8
    • absence presence and acute respiratory sars cov syndrome cov: 1, 2, 3
    • absence presence and adaptive immune response: 1, 2
    • absence presence and adaptive innate: 1, 2
    • absence presence and adhesion molecule: 1, 2, 3, 4
    • acetate pma and acute ards respiratory distress syndrome: 1
    • acetate pma and acute lung injury: 1
    • acid inducible and activation result: 1, 2
    • acid inducible and active antiviral: 1
    • acid inducible and acute lung injury: 1
    • acid inducible and adaptive immune response: 1, 2, 3, 4, 5
    • acid inducible and adaptive innate: 1, 2